Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neoadjuvant therapy in melanoma: the next step?

Literature DB >> 29361473

Neoadjuvant therapy in melanoma: the next step?

Paolo A Ascierto¹, Alexander M M Eggermont².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 29361473 DOI： 10.1016/S1470-2045(18)30016-0

Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Authors: Zeynep Eroglu; Jennifer Eatrides; Syeda Mahrukh Hussnain Naqvi; Youngchul Kim; Jeani Rich; Nalan Akgul Babacan; Andrew S Brohl; Joseph Markowitz; Amod Sarnaik; Jonathan Zager; Nikhil I Khushalani; Vernon K Sondak; Jane Messina
Journal: Pigment Cell Melanoma Res Date: 2019-09-12 Impact factor: 4.693

2. Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

Authors: Alexander M M Eggermont; Christian U Blank; Mario Mandala; Georgina V Long; Victoria G Atkinson; Stéphane Dalle; Andrew M Haydon; Andrey Meshcheryakov; Adnan Khattak; Matteo S Carlino; Shahneen Sandhu; James Larkin; Susana Puig; Paolo A Ascierto; Piotr Rutkowski; Dirk Schadendorf; Rutger Koornstra; Leonel Hernandez-Aya; Anna Maria Di Giacomo; Alfonsus J M van den Eertwegh; Jean-Jacques Grob; Ralf Gutzmer; Rahima Jamal; Paul C Lorigan; Alexander C J van Akkooi; Clemens Krepler; Nageatte Ibrahim; Sandrine Marreaud; Michal Kicinski; Stefan Suciu; Caroline Robert
Journal: J Clin Oncol Date: 2020-09-18 Impact factor: 44.544

3. Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.

Authors: Qi Wan; Chengxiu Liu; Chang Liu; Weiqin Liu; Xiaoran Wang; Zhichong Wang
Journal: Front Oncol Date: 2020-11-24 Impact factor: 6.244

Neoadjuvant therapy in melanoma: the next step?

1. Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

2. Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

3. Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.

4. Machine Learning Analysis of Immune Cells for Diagnosis and Prognosis of Cutaneous Melanoma.

Review 5. Predictive factors of neoadjuvant immune checkpoint blockade in melanoma.

6. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma.